OOIR: Observatory of International Research

Papers

(The TQCC of European Neuropsychopharmacology is 0. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)

Article	Citations
T58. EXPLORATION OF GENETIC AND CLINICAL HETEROGENEITY IN AUTISM BY CLUSTERING GENES BASED ON BULK AND SINGLE-CELL TRANSCRIPTOMIC DATA	402
11. ESTABLISHING THE MOLECULAR FOUNDATION OF BRAIN ANATOMY IN LIVING INDIVIDUALS	112
T47. A MULTI-OMIC QTL ANALYSIS OF MAJOR DEPRESSIVE DISORDER	106
T84. AN INVESTIGATION ON GENETIC MECHANISMS UNDER CLINICAL HETEROGENEITY IN SCHIZOPHRENIA	102
F41. AMBER: ANTIDEPRESSANT MEDICATIONS: BIOLOGY, EXPOSURE AND RESPONSE	101
T56. DIP2A, HIGHLY EXPRESSED GENE IN THE CEREBELLUM, IS ASSOCIATED WITH A WIDE RANGE OF PSYCHIATRIC SYMPTOMS (DELAYED SPEECH, AUTISM SPECTRUM DISORDER AND SPECIFIC LEARNING DISABILITIES)	87
T13. GENETIC ASSOCIATIONS OF ICD-DERIVED PSYCHIATRIC DIAGNOSES WITH SELF-REPORTED MENTAL HEALTH PHENOTYPES IN THE UK BIOBANK	74
F8. THE DEVELOPMENTAL LANDSCAPE OF NEUROPSYCHIATRIC GENOMICS IN AFRICA	73
T78. GENE-ENVIRONMENT INTERACTION STUDY ON THE CORRELATES FOR PSYCHOTIC EXPERIENCES IN THE UK BIOBANK	67
T100. CHILD SUBCORTICAL BRAIN VOLUMES: THE INTERACTION BETWEEN GENETIC RISK AND MATERNAL PSYCHOLOGICAL DISTRESS DURING PREGNANCY	66
41. CHARACTERIZING FUNCTIONAL CONVERGENCE OF COMMON POLYGENIC VARIATION IN NEUROPSYCHIATRIC DISORDER RISK GENES	65
F75. PREDICTION OF TREATMENT-RESISTANT SCHIZOPHRENIA USING REAL-WORLD DATA AND MULTIMODAL ANALYTICAL TOOLS	65
F97. DIFFERENTIAL EXPRESSION OF MICRORNAS UPON IN VITRO LITHIUM AND VALPROATE EXPOSURE TO BIPOLAR DISORDER PATIENTS-DERIVED LCLS	65
85. DETECTION OF PLACENTAL SCHIZOPHRENIA RISK GENES	62
1. DEVELOPMENTAL TRAJECTORIES OF DNA METHYLATION IN NEURAL CELL POPULATIONS IN HUMAN CORTEX AND LINKS TO NEURODEVELOPMENTAL DISORDERS	61
2. ENRICHMENT OF RARE, DAMAGING VARIANTS IN SCHIZOPHRENIA-RELATED GENES IN INTELLECTUAL DISABILITY PATIENTS WITH PSYCHOTIC DISORDERS	54
T35. SHARED GENETIC LIABILITY FOR ALCOHOL CONSUMPTION, ALCOHOL PROBLEMS, AND SUICIDAL BEHAVIOR: EVALUATING THE ROLE OF IMPULSIVITY	52
T33. USING GENOMICS TO AID EARLY DIFFERENTIAL DIAGNOSIS BETWEEN BIPOLAR DISORDER AND MAJOR DEPRESSION	52
T59. A GENOME-WIDE ASSOCIATION STUDY OF EATING DISORDER SYMPTOMS BASED ON THE SCOFF QUESTIONNAIRE	50
T67. ASSOCIATIONS BETWEEN METHYLATION AGE AND BRAIN AGE IN LATE ADOLESCENCE	50
6. DE NOVO MUTATIONS IN BIPOLAR DISORDER IMPLICATE GENES INVOLVED IN NEURODEVELOPMENT AND IMMUNITY	46
F48. INVESTIGATING POTENTIAL RELATIONSHIPS BETWEEN PIGMENTATION GENETICS AND PARKINSON'S DISEASE (PD)	45
W101. EPIGENETIC PROFILES OF LATENT CLASSES FOR POLYSUBSTANCE USE DISORDER	44
Society Calendar	44
HOW PARTICIPATING IN CAMH'S PHARMACOGENETICS IMPACT STUDY CHANGED MY LIFE	43

F7. THE ASSOCIATIONS BETWEEN EDUCATIONAL EXPERIENCES AND MENTAL HEALTH FROM CHILDHOOD TO YOUNG ADULTHOOD	41
W64. FAMILY BASED ASSOCIATION AND LINKAGE ANALYSES OF FAMILIAL ADHD	40
POLYGENIC RISK SCORES FOR PROBLEMATIC SUBSTANCE USE IN ADOLESCENTS: AN ENIGMA-ADDICTION STUDY	38
Comparative effectiveness of mood stabilizers and antipsychotics in the prevention of hospitalization after lithium discontinuation in bipolar disorder	37
8. A CROSS-POPULATION GENOME-WIDE ASSOCIATION STUDY OF SLEEP DURATION	36
DECOLONISATION OF PSYCHIATRIC GENETICS: PERSPECTIVES FROM AN ERSTWHILE “JEWEL IN THE CROWN” COLONY	35
THE ASSOCIATION BETWEEN POLYGENIC RISK FOR SCHIZOPHRENIA AND BRAIN AGE IN A POPULATION-BASED SAMPLE OF YOUNG ADULTS: A RECALL-BY-GENOTYPE-BASED APPROACH	34
NOVEL LOCI AND TARGET GENES INFLUENCING FUNCTIONAL SEIZURES IDENTIFIED IN A MULTI-SITE GENOME-WIDE ASSOCIATION STUDY META-ANALYSIS IN A SAMPLE OF 570,460 PATIENTS	34
DO POOR DIET AND LIFESTYLE BEHAVIOURS EXACERBATE THE GENETIC RISK OF IMPULSIVITY IN THE GENERAL POPULATION	33
The association of CNR1 genetic variants with resting-state functional connectivity in youth bipolar disorder	33
GENETIC COUNSELING FOR PSYCHIATRIC CONDITIONS	33
Editorial Board	33
PUMAS: POPULATIONS UNDERREPRESENTED IN MENTAL ILLNESS ASSOCIATION STUDIES PROJECT	32
T8. TREATMENT WITH GALANTAMINE IN 15Q13.3 DELETIONS: GENOMICALLY-INFORMED PRECISION MEDICINE STRATEGIES IN NEURODEVELOPMENTAL DISORDERS	31
W87. RARE, PATHOGENIC COPY NUMBER VARIANTS CO-SEGREGATE WITH SCHIZOPHRENIA IN PEDIGREE COHORT	29
T121. MULTI-OMIC NETWORK ANALYSIS IDENTIFIES KEY NEUROBIOLOGICAL PATHWAYS IN OPIOID ADDICTION	29
F94. SIGNIFICANT TELOMERE SHORTENING IN MALAYSIAN PATIENTS WITH SCHIZOPHRENIA: RELATIONSHIP WITH TOTAL ANTIOXIDANT CAPACITY AND OTHER COVARIATES	28
25. EPIGENOME-WIDE META-ANALYSIS OF > 3200 MILITARY AND CIVILIAN PARTICIPANTS IDENTIFIES CELL-TYPE SPECIFIC DNA METHYLATION SIGNALS ASSOCIATED WITH PTSD	28
T70. A COMPUTATIONAL TRANSCRIPTOMICS APPROACH TO DRUG REPURPOSING IDENTIFIES NEW THERAPEUTIC CANDIDATES FOR TREATMENT OF CHRONIC PAIN	27
DIFFERENTIAL ISOFORM USAGE IN SCHIZOPHRENIA	27
37. CONVERGENT IMPACT OF SCHIZOPHRENIA RISK GENES	26
ECNP Calendar of Meetings	26
Editorial Board	25
Muscle and the mind: The combination of creatine and exercise for depression	25
Opioid use and misuse in Europe: COVID-19 new challenges?	25
A specific GPR56/ADGRG1 splicing isoform is associated with antidepressant response in major depressive disorder	24
Norepinephrine system dysconnectivity in major depressive disorder: the effect of short term SSRI treatment	24
Sodium nitroprusside enhances the antipsychotic-like effect of olanzapine but not clozapine in the conditioned avoidance response test in rats	23
W2. MULTIVARIABLE GENE ENVIRONMENT INTERACTION IN THE PREDICTION OF PROSOCIAL BEHAVIOR	22
T39. POLYGENIC RISK AND CHILDHOOD TRAUMA AS PREDICTORS OF SUICIDE RISK IN BIPOLAR DISORDER	22
T33. MULTI-OMICS MACHINE LEARNING APPROACHES TO ELUCIDATE BIOLOGICAL SIGNATURES OF DEPRESSION: INSIGHTS FROM THE UK BIOBANK	22
BEYOND STANDARD GWAS IN BIPOLAR DISORDER: INTEGRATIVE FINE-MAPPING, MULTI-TRAIT, AND EPIGENETIC APPROACHES FOR CAUSAL VARIANT DISCOVERY	22
W87. PREDICTORS OF ALCOHOL CONSUMPTION: THE ROLE OF GENETICS AND IMPULSIVITY FROM ADOLESCENCE TO ADULTHOOD	22
M70. INTRODUCTION TO THE MOUNT SINAI MILLION SCHIZOPHRENIA DISCOVERIES PROGRAM (MSM-SCZ)	22
ELECTRONIC HEALTH RECORDS AND BIOBANKS IN THE ERA OF COMPUTATIONAL AND GENOMIC PSYCHIATRY	21
M74. RE-EVALUATING THE ROLE OF 22Q11 DELETION SYNDROME (22Q11DS) IN SCHIZOPHRENIA	21
W17. CONCORDANT AND DISCORDANT GENETIC VARIANTS ASSOCIATED WITH MENTAL ILL-HEALTH AND THEIR IMPACT ON CARDIOMETABOLIC RISK	20
87. ATLAS OF PHENOTYPE-GENOTYPE RELATIONSHIPS BETWEEN PLASMA METABOLIC MARKERS, BRAIN MORPHOLOGY AND PSYCHIATRIC DISORDERS	20
3. MODELING AGE-DEPENDENT GENETIC EFFECTS ON TEMPERAMENT AND MENTAL HEALTH	20
W47. THE GENETIC ARCHITECTURE OF DIFFICULT-TO-TREAT DEPRESSION: A PHARMLINES INITIATIVE COHORT STUDY	20
The future of antipsychotics studies: How innovative designs may benefit patients with psychotic disorders	20
Transcriptional biomarkers of response to pharmacological treatments in severe mental disorders: A systematic review	19
The effects of transient receptor potential cation channel inhibition by BI 1358894 on cortico-limbic brain reactivity to negative emotional stimuli in major depressive disorder	19
Editorial Board	19
17. LANDSCAPE SURVEY OF 8853 CLINICAL TRIALS IN DEPRESSION TO IDENTIFY NEW TREATMENT RESPONSE PHARMACOGENETIC STUDIES	19
Exploring the link between functional connectivity of ventral tegmental area and physical fitness in schizophrenia and healthy controls	19
Stress, mental disorder and ketamine as a novel, rapid acting treatment	19
Clinical and psychopathological correlates of duration of untreated illness (DUI) in affective spectrum disorders	19
Editorial Board	19
W38. INVESTIGATION OF GENE-ENVIRONMENT INTERACTIONS BETWEEN GENETICALLY REGULATED GLUCOCORTICOID REACTIVITY AND STRESSFUL LIFE EVENTS IN MAJOR DEPRESSIVE DISORDER	18

W31. KETAMINE AND ELECTROCONVULSIVE THERAPY DEPRESSION TREATMENTS ALTER ISOFORM- AND CELL TYPE-SPECIFIC TRANSCRIPTOMES IN THE MOUSE PREFRONTAL FRONTAL CORTEX	18
F11. PATTERNS OF GENETIC OVERLAP BETWEEN BIPOLAR DISORDER, SUBSTANCE USE DISORDERS AND SUBSTANCE CONSUMPTION PHENOTYPES REVEAL DISTINCT FACTORS OF PATHOLOGY	17
T3. DEPRESSION ASSOCIATED GENETIC, TRANSCRIPTOMIC AND PATHWAY -LEVEL PROFILING OF TRAUMA-EXPOSED MILITARY AND CIVILIAN COHORTS	17
F10. TRACES OF ASSORTATIVE MATING FOR MENTAL DISORDERS IN THE HUMAN GENOME	17
T71. GENETIC AND ENVIRONMENTAL ASSOCIATION BETWEEN PRESENT MOMENT ATTENTION AND SUBJECTIVE WELLBEING	17
F99. GENETIC CORRELATION OF CHILDHOOD AGGRESSION WITH MENTAL AND GENERAL HEALTH TRAITS	17
T75. ASSOCIATIONS BETWEEN POLYGENIC RISK SCORE FOR SCHIZOPHRENIA AND SCHIZOTYPAL TRAITS IN THE MULTIPLEX FAMILIES OF PATIENTS WITH SCHIZOPHRENIA	17
LONGITUDINAL GENETIC APPROACHES IN MENTAL HEALTH: INTERNATIONAL PERSPECTIVES AND OPPORTUNITIES	16
75. GWAS IDENTIFIES NOVEL LOCI ASSOCIATED WITH SPECIFIERS OF BIPOLAR DISORDER	16
F59. DISENTANGLING THE OVERLAP BETWEEN SUICIDE ATTEMPT AND ASSOCIATED PHENOTYPES USING LOCAL GENETIC CORRELATIONS	16
INNOVATING KNOWLEDGE DISSEMINATION FOR CULTURAL RELEVANCE AND ACCESSIBILITY	16
ABSENCE OF NONFATAL SUICIDAL BEHAVIOR PRECEDING SUICIDE DEATH REVEALS CLINICAL AND GENETIC RISK DIFFERENCES	16
W17. REGIONAL GENETIC ARCHITECTURE OF THE CORPUS CALLOSUM AND ITS OVERLAP WITH PSYCHIATRIC AND SUBSTANCE USE PHENOTYPES	16
20. PHENOME-WIDE ASSOCIATION STUDY OF COGNITIVE FUNCTION IN MULTIETHNIC ASIAN POPULATION	16
46. PATHWAY-BASED POLYGENIC RISK SCORES USING MACHINE LEARNING: APPLICATION TO SCHIZOPHRENIA AND BIPOLAR DISORDER	15
87. RS148582811 REGULATES ITS HOST GENE ARVCF EXPRESSION TO AFFECT NICOTINE-ASSOCIATED HIPPOCAMPUS-DEPENDENT MEMORY	15
PRS PREDICTION BEYOND FAMILY HISTORY	15
W32. A GENOME-WIDE ASSOCIATION STUDY OF BIPOLAR DISORDER FROM INDIA	15
54. EXAMINING COMMON AND SPECIFIC GENETIC INFLUENCES ON SCHIZOPHRENIA, BIPOLAR DISORDER, AND DEPRESSION	15
W9. IDENTIFYING CENTRAL AND TRANS-DIAGNOSTIC PSYCHIATRIC SYMPTOMS COMBINING NETWORK ANALYSIS AND GENETICS	15
DECODING CELL TYPE-SPECIFICITY THROUGH SYSTEMATIC CELL TYPE ANNOTATIONS OF SINGLE-CELL RNA SEQUENCING DATA AMONG TISSUES AND APPLICATION TO PSYCHIATRIC DISORDERS AND OTHER TRAITS	14
TREML2 IN THE CONTEXT OF WHITE MATTER HYPERINTENSITIES AND ALZHEIMER'S DISEASE	14
Prader Willi syndrome, its psychiatric implications and their possible biological basis	14
WHOLE EXOME SEQUENCING IN AN AUTISM MULTIPLEX FAMILY OF INDIAN ORIGIN REVEALS INCREASED GENETIC BURDEN OF MATERNALLY TRANSMITTED VARIANTS	14
MULTI-ANCESTRY GENOME-WIDE ASSOCIATION STUDIES PROVIDE NOVEL BIOLOGICAL INSIGHTS INTO THE GENETIC ARCHITECTURE OF BIPOLAR DISORDER	14
T68. DDR1 PROMOTER METHYLATION IN DIFFERENT PSYCHIATRIC DISORDERS AND ITS RELATIONSHIP TO NEUTROPHIL-TO-LYMPHOCYTE RATIOS	14
Psychopathology for the twenty-first century: Towards a ChatGPT psychopathology?	14
PRESENTING A MULTIDISCIPLINARY FRAMEWORK FOR RESEARCH GENOME SEQUENCING COUPLED WITH GENETIC COUNSELING AND RETURN OF CLINICALLY VALIDATED PRIMARY AND SECONDARY FINDINGS FOR INDIVIDUALS WITH PSYCHIATR	14
Letter to editor about the article “Clinical features in co-occuring obsessive-compulsive disorder and bipolar disorder: A systematic review and meta-analysis” (De Prisco M et al.,2023)	14
A randomised, placebo-controlled, double blind, crossover trial on the effect of a 20:1 cannabidiol: Δ9-tetrahydrocannabinol medical cannabis product on neurocognition, attention, and mood	14
ECNP Calendar of Meetings	13
F3. METABOLIC EFFECT OF CYP2C19 AND CYP2D6 ON ANTIDEPRESSANT RESPONSE: A META-ANALYSIS OF 13 DEPRESSION PHARMACOGENETIC STUDIES	13
Social Stress in Bipolar Disorder	13
Neuroimaging revealed long-lasting glucose metabolism changes to morphine withdrawal in rats pretreated with the cannabinoid agonist CP-55,940 during periadolescence	13
GENOMIC STRUCTURAL EQUATION MODELING APPLIED TO 14 MAJOR PSYCHIATRIC DISORDERS	13
W14. EXPLORING THE RELATIONSHIP BETWEEN GENETIC PREDISPOSITION TO MENTAL HEALTH DISORDERS AND THE SOCIAL ENVIRONMENT IN THE UK BIOBANK	13
EXOME SEQUENCING TECHNOLOGY AND ANALYSIS	13
POLYGENIC SCORE OF POST-TRAUMATIC STRESS DISORDER HIGHLIGHTS ASSOCIATION WITH CARDIOVASCULAR DISORDERS IN ELECTRONIC HEALTH RECORDS OF >94,000 INDIVIDUALS	13
T23. ASSOCIATION OF CHILDHOOD TRAUMA EXPOSURE WITH DDR1 PROMOTER METHYLATION IN BIPOLAR DISORDER	13
Number needed to treat and number needed to harm: What are they good for?	13
Letter to the editor concerning: “Antipsychotic drug dosing and study discontinuation in schizophrenia: A systematic review and dose-response meta-analysis”	13
ASSESSING THE UTILITY OF PHARMACOGENETIC TESTING IN A COHORT WITH TREATMENT-RESISTANT SCHIZOPHRENIA OR SCHIZOAFFECTIVE DISORDER	13
32. PRINCIPAL AND INDEPENDENT GENOMIC COMPONENTS OF BRAIN STRUCTURE AND FUNCTION: ROBUSTNESS AND RELEVANCE	12
W35. INVESTIGATION OF RELATIONSHIPS BETWEEN INTERNALIZING, EXTERNALIZING, AND RISKY SEXUAL BEHAVIOR: A GENETICALLY-INFORMATIVE SAMPLE	12
73. IMPACT OF GENETIC RISK VARIANTS OF MENTAL DISORDERS ON EPIGENETIC REGULATION: AN MQTL APPROACH	12
T95. ITERATING TOWARDS PRECISION PHENOTYPING OF SCHIZOPHRENIA IN THE ELECTRONIC HEALTH RECORD	12
W6. INTERACTION BETWEEN BDNF METHYLATION, SUICIDAL IDEATION, AND LONG-TERM OUTCOMES AFTER STROKE	12
Corrigendum to “Modelling decision-making under uncertainty: A direct comparison study between human and mouse gambling data” [31, February 2020, Pages 58–68]	12
86. AN INTERNATIONAL, CASE-CASE MEGA-ANALYSIS OF TREATMENT-RESISTANT SCHIZOPHRENIA VERSUS NON-TREATMENT RESISTANT SCHIZOPHRENIA	12
Serotonin 5-HT2A receptors in schizophrenia: Reflexions on an unfinished story	12
W97. A GENOMEWIDE ASSOCIATION STUDY OF ANTIPSYCHOTIC INDUCED EXTRAPYRAMIDAL SIDE EFFECTS	12
T65. GENES IN POSTMORTEM BRAIN TISSUE DIFFERENTIALLY EXPRESSED IN CHRONIC PAIN	11
PHARMACOGENETICS OF ANXIETY AND OBSESSIVE-COMPULSIVE DISORDERS	11
SLEEP INERTIA DRIVES THE ASSOCIATION OF EVENING CHRONOTYPE WITH PSYCHIATRIC DISORDERS: GENETIC AND EPIDEMIOLOGICAL EVIDENCE	11
W12. BIDIRECTIONAL CROSS-TRAIT GENETIC NURTURE BETWEEN INTERNALIZING AND SUBSTANCE USE DOMAINS	11
16. HOW DO PATIENTS WITH MAJOR DEPRESSION RESPOND TO DOSAGE INCREMENTS OF ANTIDEPRESSANTS? A CLINICAL AND GENETIC INVESTIGATION IN UK BIOBANK	11
EVALUATING THE CAUSAL RELATIONSHIP BETWEEN EDUCATIONAL ATTAINMENT AND MENTAL HEALTH	11
W44. UNVEILING GENETIC ARCHITECTURES FOR STRATIFYING TRAJECTORIES OF ADOLESCENT DEPRESSION	11
Prescription sequences in bipolar disorder – A nationwide Danish register-based study of 19,927 individuals followed for 10 years	11
POPULATION MEDICAL GENOMICS IN LATIN AMERICA	11
M45. OPEN BOARD	11
As in cooking, so in medicine: Doses do matter	11
Pediatric Bipolar Disorder – Misinformation with Unintended Negative Consequences for Children and Adolescents	11
M25. POLYGENIC RISKS AND CARDIOVASCULAR TREATMENT EFFECTS IN SEVERE MENTAL ILLNESS	11
W1. CAN RESPONSE TO PSYCHOTHERAPY IN OBSESSIVE-COMPULSIVE DISORDER BE PREDICTED FROM DNA METHYLATION DATA?	11
Effects of quetiapine on sleep: A systematic review and meta-analysis of clinical trials	10
INSIGHTS INTO THE METABOLIC ORIGINS OF ANOREXIA NERVOSA THROUGH GENOMICS AND NEUROIMAGING	10
W66. NEUROBIOLOGICAL CORRELATES OF MALE SEXUAL ORIENTATION	10
Regarding the meta-analyses of pharmacogenomics-guided antidepressant treatment: A response to Milosavljevic et al.	10
Exploring the incidence of inadequate response to antidepressants in the primary care of depression	10
Associations between individual depressive symptoms and immunometabolic characteristics in major depression	10
Comparative analysis of anticholinergic burden scales to explain iatrogenic cognitive impairment and self-reported side effects in the euthymic phase of bipolar disorders: Results from the FACE-BD coh	10
W88. GENETICALLY FASTER CYP2A6-MEDIATED NICOTINE METABOLISM INCREASES SMOKING-RELATED DISEASE RISK: A PHENOME-WIDE ASSOCIATION STUDY IN THE ALL OF US RESEARCH PROGRAM	10
W54. DETECTION OF DIFFERENTIALLY EXPRESSED GENES IN IPSC-DERIVED TROPHOBLAST CULTURES FROM CONTROLS AND PATIENTS WITH SCHIZOPHRENIA	10
T62. EXPLORING THE LANDSCAPE OF GENETIC TESTING FOR AUTISM: PERSPECTIVES FROM AUTISTIC INDIVIDUALS, FAMILIES, AND PHYSICIANS AND TRENDS IN HEALTHCARE DATA IN ALBERTA, CANADA	10
BEYOND BORDERS: INTEGRATING TRAINING AND RESEARCH FOR SCIENTIFIC EXCELLENCE AND GLOBAL EQUITY	10
Exploring the relationship between the gut microbiome and mental health outcomes in a posttraumatic stress disorder cohort relative to trauma-exposed controls	10
Current level of evidence for improvement of antidepressant efficacy and tolerability by pharmacogenomic-guided treatment: A Systematic review and meta-analysis of randomized controlled clinical trial	10
F93. CELL-TYPE SPECIFIC TRANSCRIPTOMIC PROFILING IN SCHIZOPHRENIA IDENTIFIES CHANGES IN GABAERGIC NEURONS AND OLIGODENDROCYTES AT TRANSCRIPT LEVEL	10
M21. POLYGENICITY OF ANOREXIA NERVOSA AT THE PATHWAY LEVEL	10

AN INTERNATIONAL, CASE-CASE META-ANALYSIS OF TREATMENT RESISTANT SCHIZOPHRENIA VERSUS NON-TREATMENT RESISTANT SCHIZOPHRENIA	10
THE ROLE OF SEX IN POLYGENIC RISK FOR SEX-BIASED BRAIN DISORDERS	10
Antidepressant use in pregnancy and neonatal outcomes: reassuring findings from an asian cohort	10
Cell type-specific methylome-wide association studies of childhood ADHD symptoms	10
13. DISTINGUISHING DIFFERENT PSYCHIATRIC DISORDERS USING DDX-PRS	9
GENOME-WIDE GENE-GENE INTERACTION OF THE 5-HTTLPR PROMOTER POLYMORPHISM EMPHASIZES THE IMPORTANT ROLE OF NEUROPLASTICITY IN DEPRESSION	9
GENOME-WIDE ASSOCIATION STUDIES OF ANOREXIA NERVOSA: AN OVERVIEW, UPDATE, AND IMPLICATIONS	9
T54. FIRST GWAS ON AFFECTIVE TEMPERAMENTS IDENTIFIES NOVEL GENOME-WIDE SIGNIFICANT VARIANT FOR ANXIOUS TEMPERAMENT AND SUGGESTIVE VARIANTS FOR ALL FIVE AFFECTIVE TEMPERAMENTS	9
F44. DIFFERENCES IN POLYGENIC RISK SCORE FOR MAJOR DEPRESSIVE DISORDER DEPENDING ON CASE DEFINITION IN AN ELECTRONIC HEALTH RECORDS STUDY	9
T28. EXPLORING THE RELATIONSHIP BETWEEN ACNE AND MENTAL HEALTH DISORDERS	9
The genetics of treatment-resistant depression: controversies and perspectives	9
PERCEPTIONS OF CAUSAL ATTRIBUTION AND ATTITUDES TO GENETIC TESTING AMONG PEOPLE WITH SCHIZOPHRENIA AND THEIR FIRST-DEGREE RELATIVES	9
41. USING BRAIN CELL-TYPE-SPECIFIC INTERACTOMES OF PROTEINS ENCODED BY RISK GENES TO UNCOVER BIOLOGY UNDERLYING SCHIZOPHRENIA AND RELATED DISORDERS	9
AN ONTOLOGICAL BASED APPROACH TO CHARACTERIZE THE BEHAVIORAL DIFFERENCES BETWEEN PATIENTS WITH 16P11.2 DUPLICATION AND DELETION	9
F39. CONTRIBUTION OF COMMON POLYGENIC VARIATION TO THERAPY RESPONSE IN THE EARLY MEDICATION CHANGE COHORT	9
94. AN INDUCED PLURIPOTENT STEM CELL (IPSC) RESOURCE FROM GENETICALLY ISOLATED FAMILIES WITH NEUROPSYCHIATRIC DISORDERS	9
HOW DO WE MAKE POLYGENIC RISK SCORES (PRS) UNDERSTANDABLE? THE DEVELOPMENT AND EVALUATION OF A NEW TOOL TO ACCOMPANY PRS	9
Disease continuum centered on Parkinson's disease	9
T85. INVESTIGATING THE GENETIC ARCHITECTURE OF REGIONAL BRAIN STRUCTURE AND ITS RELATIONSHIP TO SCHIZOPHRENIA	9
F80. A DNA METHYLATION STUDY OF COMMON AND SPECIFIC TREATMENT EFFECTS OF THREE ANTIPSYCHOTICS IN THE TREATMENT OF PSYCHOSIS	9
26. UNRAVELING THE HETEROGENEITY OF PTSD SYMPTOMS THROUGH IDENTIFYING EPIGENETIC SUBTYPES AMONG TRAUMA-EXPOSED CIVILIAN WOMEN	8
Clinician- versus caregiver-rated scales as outcome measures of repetitive-restricted behaviors in clinical trials of autism: A systematic review and meta-analysis	8
CONTRIBUTION OF GENOME SEQUENCING IN THE EVALUATION OF CHILDREN AND ADOLESCENTS WITH SUSPECTED SERONEGATIVE AUTOIMMUNE ENCEPHALITIS	8
57. TRANSCRIPTOMIC DYSFUNCTION DISPARITIES: GREATER BURDEN IN FEMALE BRAINS HIGHLIGHTS IMMUNE AND SYNAPTIC PATHWAYS FOR PSYCHIATRIC DISORDERS	8
IMMUNO-PSYCHIATRY AND INFLAMMATION	8
W23. GENOME-WIDE ASSOCIATION STUDY OF UNCONTROLLED EATING	8
I WOULDN'T TREAT A [POLYGENIC RISK] SCORE WITH PILLS	8
VARIANCE QUANTITATIVE TRAIT LOCI MAPPING IN THE MOBA COHORT: DETECTING INTERACTION EFFECTS INVOLVED IN DEVELOPMENTAL OUTCOMES	8
W85. EVALUATION OF THE PSYCHOMETRIC PROPERTIES OF THE UBACC QUESTIONNAIRE IN ASSESSING CAPACITY TO CONSENT IN DIVERSE AFRICAN POPULATIONS	8
EXPANDING OUR UNDERSTANDING OF GENETIC RISK FOR BINGE EATING VIA A GENOME-WIDE ASSOCIATION STUDY	8
CHARACTERIZING THE LOCAL GENETIC CORRELATIONS BETWEEN 14 MAJOR PSYCHIATRIC DISORDERS	8
MERGING THE BOUNDARIES BETWEEN THE BRAIN AND THE HEART: UNDERSTANDING THE SHARED BIOLOGY OF MOOD DISORDERS AND CARDIO-METABOLIC PHENOTYPES USING GENETICS, GENOMICS AND ELECTRONIC HEALTH RECORD DATA	8
How else can inflammation kill you?	8
Assessing risk for bipolar disorder. Comments on ``Young people at risk for developing bipolar disorder: Two-year findings from the multicenter prospective, naturalistic Early-BipoLife study'' (Martin	8
PRELIMINARY RESULTS FROM THE FIRST SPANISH GWAS ON DEPRESSION IN THE EPIDEMIOLOGICAL PISMA-EP STUDY.	8
F57. INVESTIGATION OF THE SEX CHROMOSOMES IN AUTISM SPECTRUM DISORDER	8
THE GENETIC ARCHITECTURE OF BEAT SYNCHRONIZATION THROUGH A NEURODEVELOPMENTAL AND NEURO-FUNCTIONAL LENS	8
INTEGRATING POLYGENIC RISK SCORES WITHIN TWIN MODELLING TO INVESTIGATE THE CAUSAL RISK FACTORS FOR SELF-HARM	8
F73. CLINICAL AND GENETIC TRAUMA-RELATED RISK FACTORS LEADING TO SUICIDE DEATH	8
F59. DISSECTING THE CONTRIBUTIONS OF RARE AND COMMON GENETIC VARIATION TO NEURODEVELOPMENTAL OUTCOMES	8
THE IMPACT OF EARLY ADVERSITY AND EDUCATIONAL ATTAINMENT ON GENETIC AND BRAIN MORPHOLOGICAL PREDICTORS OF INTELLIGENCE	8
FINE-MAPPING ACROSS DIVERSE ANCESTRIES DRIVES THE DISCOVERY OF PUTATIVE CAUSAL VARIANTS UNDERLYING HUMAN COMPLEX TRAITS AND DISEASES	8
T82. ASSOCIATION OF SCHIZOPHRENIA POLYGENIC RISK SCORES WITH TREATMENT-RESISTANT SCHIZOPHRENIA	8
Killing me softly: Alcohol addiction today	8
Neuroscience-based nomenclature of psychotropics: Progress report	8
FUNCTIONAL GENOMIC APPROACHES WITH SINGLE-CELL RESOLUTION PROVIDE MECHANISTIC AND BIOLOGICAL INSIGHTS BASED ON GENETIC ASSOCIATION STUDIES	7
SHARED CARDIOVASCULAR RISK FACTORS AND GENETIC OVERLAP OF POSTPARTUM DEPRESSION AND MAJOR DEPRESSIVE DISORDER	7
W76. CONFIRMATORY FACTOR ANALYSES OF PSYCHOSIS SYMPTOMS EXHIBIT MEASUREMENT NONINVARIANCE ACROSS CLINICAL PHASE OF ILLNESS IN SCHIZOPHRENIA, SCHIZOAFFECTIVE DISORDER, AND BIPOLAR I DISORDER	7
75. MIR1255A REGULATES PATHWAYS CRITICAL FOR BRAIN DEVELOPMENT, RISK GENES FOR DEPRESSION AND NEURODEVELOPMENTAL DISORDERS	7
T37. GENOME-WIDE ASSOCIATION STUDY (GWAS) OF ANTIDEPRESSANT TREATMENT RESPONSE IN MAJOR DEPRESSIVE DISORDER IN JAPANESE POPULATION	7
RARE CODING VARIANTS IN 195,257 INDIVIDUALS REVEAL 29 NOVEL BIPOLAR DISORDER GENES AND STRUCTURAL MISSENSE HOTSPOTS IN PROTEIN SPACE	7
REMOVING PLEIOTROPIC SIGNALS REVEAL DISEASE-SPECIFIC GENETIC ARCHITECTURE IN NOISY, SHALLOW BIOBANK PHENOTYPES	7
66. INTEGRATED SINGLE-CELL MULTIOMIC PROFILING OF CAUDATE NUCLEUS SUGGESTS KEY MECHANISMS IN ALCOHOL USE DISORDER	7
W71. LONGITUDINAL BIOPSYCHOSOCIAL MARKERS OF POSTTRAUMATIC OUTCOMES IN A DIVERSE GROUP OF EMERGENCY RESPONDERS	7
T60. GENETIC CORRELATES OF AGE AT AUTISM DIAGNOSIS IS ASSOCIATED WITH VARYING MENTAL HEALTH AND DEVELOPMENTAL PROFILES, AND HETEROGENEITY IN AUTISM	7
T4. SHARED GENETIC RISK FACTORS CONTRIBUTE TO THE RELATIONSHIP BETWEEN NAUSEA AND VOMITING IN PREGNANCY AND MENTAL HEALTH CONDITIONS	7
33. GENETIC REGULATION OF HUMAN BRAIN RNA EDITING IN EAST ASIAN	7
MULTIVARIATE GENOME-WIDE ASSOCIATION STUDY OF PTSD, ALCOHOL USE AND ALCOHOL USE DISORDERS	7
METHODS FOR UNDERSTANDING GENETIC CONTRIBUTIONS TO LIFECOURSE MENTAL DISORDERS	7
COMBINING GENETIC AND NEUROIMAGING RISK SCORES FOR THE PREDICTION OF PSYCHIATRIC DISORDERS	7
62. INVESTIGATING THE FAMILIAL CO-AGGREGATION OF PSYCHIATRIC, SOMATIC, AND BEHAVIORAL OUTCOMES WITH BORDERLINE PERSONALITY DISORDER IN A SWEDISH BIRTH COHORT: SHARED GENETIC OR ENVIRONMENTAL FACTORS?	7
51. GENETIC NURTURE EFFECTS IN DEPRESSIVE AND ANXIETY DISORDERS AND SYMPTOMS, AND IN RELATED TRAITS	7
PRELIMINARY INVESTIGATIONS INTO THE GUT MICROBIOME'S ROLE IN SCHIZOPHRENIA	7
Predicting 10-year risk of chronic kidney disease in lithium-treated patients with bipolar disorder: A risk model development and internal cross-validation study	7
MODELING MATERNAL INFLAMMATION AND NEURODEVELOPMENT-RELEVANT ENDPOINTS IN BRAIN ORGANOIDS	7
T86. GENOME-WIDE ASSOCIATION STUDY OF IRRITABILITY FOLLOWING SMOKING CESSATION IN A CLINICAL TRIAL	7
WHOLE GENOME SEQUENCING	7
83. CHARACTERIZING BIOPSYCHOSOCIAL FACTORS AND RELATIONSHIPS WITH CLINICAL TRAITS FOR PSYCHOTIC-LIKE EXPERIENCES IN ADOLESCENTS	7
CURRENT CHALLENGES AND OPPORTUNITIES IN DATA-DRIVEN APPROACHES IN NEUROPSYCHIATRIC DISORDERS	7
Therapygenetics: Serotonin transporter gene polymorphism (5-HTTLPR) is associated with behavioral treatment response to virtual exposure therapy in patients with spider phobia	6
“Much ado about nothing?” advocating for neuroscientific research in maternal perfectionism and perinatal mental health disorders	6
W41. ASSOCIATION OF INTESTINAL ANTI-INFLAMMATORY DRUG TARGET GENES WITH PSYCHIATRIC DISORDERS: A MENDELIAN RANDOMIZATION STUDY	6
11. GENETIC EPIDEMIOLOGY AND POLYGENICITY OF PSYCHOTIC MAJOR DEPRESSIVE DISORDER	6
W91. FAMILY BASED GENOME-WIDE ASSOCIATION ANALYSIS OF NOVELTY SEEKING IN A KOREAN SCHIZOPHRENIC POPULATION: A PILOT STUDY	6
Semaglutide suppresses cocaine taking, seeking, and cocaine-evoked dopamine levels in the nucleus accumbens	6
Antidepressant efficacy of cariprazine in bipolar disorder and the role of its pharmacodynamic properties: A hypothesis based on data	6
W98. GENETIC ARCHITECTURE AND POLYGENIC PREDICTION OF ALCOHOL USE DISORDER IN NEPAL	6
T91. IL-3RA (RS 6603272 G/T) GENE POLYMORPHISM IN THE BATAKNESE POPULATION WITH SCHIZOPHRENIA AND ITS CORRELATION TO NEGATIVE SYMPTOMS	6
T66. INVESTIGATING THE IMPACT OF DARK REGIONS OF THE GENOME ON GENOMIC RESEARCH FOR PSYCHIATRIC ILLNESS	6
Combining digital with peripheral biomarkers in bipolar disorder	6
Intranasal esketamine and manic symptoms: A disproportionality analysis in EudraVigilance	6
NEURONAL-SPECIFIC METHYLOME AND HYDROXYMETHYLOME ANALYSIS IDENTIFIES NOVEL LOCI ASSOCIATED WITH ALCOHOL USE DISORDER	6
Expression of the Transient Receptor Potential Vanilloid 1 ion channel in the supramammillary nucleus and the antidepressant effects of its antagonist AMG9810 in mice	6
F52. DNA METHYLATION AT BIRTH AS POTENTIAL MEDIATOR BETWEEN PARENTAL FACTORS AND CHILD ATTENTION DEFICIT HYPERACTIVITY DISORDER – A GENETICALLY INFORMED PROSPECTIVE COHORT STUDY	6
The effects of acute dopamine depletion on resting-state functional connectivity in healthy humans	6
Screening the European pharmacovigilance database for reports of clozapine-related DRESS syndrome: 47 novel cases	6
CONTRIBUTION OF POLYGENIC SCORES FOR A “COMMON EXECUTIVE FUNCTION” FACTOR TO COGNITIVE PERFORMANCE IN THE PSYCOURSE STUDY	6
T15. THE ROLE OF GENETIC FACTORS IN ENDURING MENTAL HEALTH AND THE ASSOCIATION WITH OTHER TRAITS	6
Letter to the editor about the article “Engineered extracellular vesicles and their promising therapeutic potential in neuropsychiatric disorders” (Schulze TG et al., 2022)	6
Immuno-psychiatry: Dreams or reality?	6
SYSTEMS BIOLOGY OF PTSD REVEALS MECHANISMS OF RISK AND DISEASE PROCESSES AT BRAIN MULTI-OMIC, BRAIN CELL TYPE, AND BLOOD LEVELS	6
T56. NEONATAL BLOOD TRANSCRIPTOMICS REVEAL EXPRESSION SIGNATURES OF ADHD RISK	6
Orbitofrontal cortex hypergyrification in hallucinating schizophrenia patients: Surface ratio as a promising brain biomarker	6
T72. RISK LOCI ASSOCIATED WITH INTERNET GAMING DISORDER IN ADOLESCENT: A GENOME-WIDE ASSOCIATION STUDY	6
Corrigendum to ‘BDNF gene polymorphisms predicting treatment response to CBT-based rehabilitation of depression’ European Neuropsychopharmacology Volume 58, May 2022, Pages 103-108	6